Found: 10
Select item for more details and to access through your institution.
MIF inhibition alleviates vitiligo progression by suppressing CD8<sup>+</sup> T cell activation and proliferation.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 84, doi. 10.1002/path.6073
- By:
- Publication type:
- Article
Re‐interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 1, doi. 10.1002/path.6070
- By:
- Publication type:
- Article
The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 17, doi. 10.1002/path.6059
- By:
- Publication type:
- Article
Liver insulin‐like growth factor‐1 mediates effects of low‐intensity vibration on wound healing in diabetic mice.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 97, doi. 10.1002/path.6068
- By:
- Publication type:
- Article
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 56, doi. 10.1002/path.6064
- By:
- Publication type:
- Article
Oncofetal protein glypican‐3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 43, doi. 10.1002/path.6063
- By:
- Publication type:
- Article
Artificial intelligence‐based digital scores of stromal tumour‐infiltrating lymphocytes and tumour‐associated stroma predict disease‐specific survival in triple‐negative breast cancer.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 32, doi. 10.1002/path.6061
- By:
- Publication type:
- Article
Automated Ki‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 5, doi. 10.1002/path.6057
- By:
- Publication type:
- Article
TUBB4B is a novel therapeutic target in non‐alcoholic fatty liver disease‐associated hepatocellular carcinoma.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 71, doi. 10.1002/path.6065
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. E1, doi. 10.1002/path.5941
- Publication type:
- Article